ASLAN Pharmaceuticals Announces Publication in Clinical Immunology Highlighting Eblasakimab's ... | News
SAN MATEO, Calif. and SINGAPORE, June 23, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (“ASLAN”, Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients,
Source: bakersfield.com